{"id":3224,"date":"2017-05-03T09:26:10","date_gmt":"2017-05-03T07:26:10","guid":{"rendered":"https:\/\/www.wemos.org\/?p=3224"},"modified":"2023-04-20T09:36:22","modified_gmt":"2023-04-20T07:36:22","slug":"eu-parliament-wants-ethically-tested-drugs-for-eu-market","status":"publish","type":"post","link":"https:\/\/www.wemos.org\/en\/eu-parliament-wants-ethically-tested-drugs-for-eu-market\/","title":{"rendered":"EU parliament wants ethically tested drugs for EU market"},"content":{"rendered":"","protected":false},"excerpt":{"rendered":"","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"categories":[41],"class_list":["post-3224","post","type-post","status-publish","format-standard","hentry","category-news"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.0 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>EU parliament wants ethically tested drugs for EU market - Wemos<\/title>\n<meta name=\"description\" content=\"The report states that the EMA ensures that drugs intended for the European market are tested ethically in lower-income countries.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.wemos.org\/eu-parlement-voor-toelating-ethische-medicijnen-op-eu-markt\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"EU parliament wants ethically tested drugs for EU market - Wemos\" \/>\n<meta property=\"og:description\" content=\"The report states that the EMA ensures that drugs intended for the European market are tested ethically in lower-income countries.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.wemos.org\/eu-parlement-voor-toelating-ethische-medicijnen-op-eu-markt\/\" \/>\n<meta property=\"og:site_name\" content=\"Wemos\" \/>\n<meta property=\"article:published_time\" content=\"2017-05-03T07:26:10+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-04-20T07:36:22+00:00\" \/>\n<meta name=\"author\" content=\"wemos\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"wemos\" \/>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"EU parliament wants ethically tested drugs for EU market - Wemos","description":"The report states that the EMA ensures that drugs intended for the European market are tested ethically in lower-income countries.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.wemos.org\/eu-parlement-voor-toelating-ethische-medicijnen-op-eu-markt\/","og_locale":"en_US","og_type":"article","og_title":"EU parliament wants ethically tested drugs for EU market - Wemos","og_description":"The report states that the EMA ensures that drugs intended for the European market are tested ethically in lower-income countries.","og_url":"https:\/\/www.wemos.org\/eu-parlement-voor-toelating-ethische-medicijnen-op-eu-markt\/","og_site_name":"Wemos","article_published_time":"2017-05-03T07:26:10+00:00","article_modified_time":"2023-04-20T07:36:22+00:00","author":"wemos","twitter_card":"summary_large_image","twitter_misc":{"Written by":"wemos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.wemos.org\/eu-parlement-voor-toelating-ethische-medicijnen-op-eu-markt\/#article","isPartOf":{"@id":"https:\/\/www.wemos.org\/eu-parlement-voor-toelating-ethische-medicijnen-op-eu-markt\/"},"author":{"name":"wemos","@id":"https:\/\/www.wemos.org\/#\/schema\/person\/28cd2e2c83a896db414b6a7132d49638"},"headline":"EU parliament wants ethically tested drugs for EU market","datePublished":"2017-05-03T07:26:10+00:00","dateModified":"2023-04-20T07:36:22+00:00","mainEntityOfPage":{"@id":"https:\/\/www.wemos.org\/eu-parlement-voor-toelating-ethische-medicijnen-op-eu-markt\/"},"wordCount":9,"articleSection":["News"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.wemos.org\/eu-parlement-voor-toelating-ethische-medicijnen-op-eu-markt\/","url":"https:\/\/www.wemos.org\/eu-parlement-voor-toelating-ethische-medicijnen-op-eu-markt\/","name":"EU parliament wants ethically tested drugs for EU market - Wemos","isPartOf":{"@id":"https:\/\/www.wemos.org\/#website"},"datePublished":"2017-05-03T07:26:10+00:00","dateModified":"2023-04-20T07:36:22+00:00","author":{"@id":"https:\/\/www.wemos.org\/#\/schema\/person\/28cd2e2c83a896db414b6a7132d49638"},"description":"The report states that the EMA ensures that drugs intended for the European market are tested ethically in lower-income countries.","inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.wemos.org\/eu-parlement-voor-toelating-ethische-medicijnen-op-eu-markt\/"]}]},{"@type":"WebSite","@id":"https:\/\/www.wemos.org\/#website","url":"https:\/\/www.wemos.org\/","name":"Wemos","description":"Wemos","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.wemos.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.wemos.org\/#\/schema\/person\/28cd2e2c83a896db414b6a7132d49638","name":"wemos","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.wemos.org\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/46e8d2c008401ec7d94c59a002d8bdb6b770ec5ef30bee9e00824978da84df90?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/46e8d2c008401ec7d94c59a002d8bdb6b770ec5ef30bee9e00824978da84df90?s=96&d=mm&r=g","caption":"wemos"}}]}},"_links":{"self":[{"href":"https:\/\/www.wemos.org\/en\/wp-json\/wp\/v2\/posts\/3224","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.wemos.org\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.wemos.org\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.wemos.org\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.wemos.org\/en\/wp-json\/wp\/v2\/comments?post=3224"}],"version-history":[{"count":1,"href":"https:\/\/www.wemos.org\/en\/wp-json\/wp\/v2\/posts\/3224\/revisions"}],"predecessor-version":[{"id":3225,"href":"https:\/\/www.wemos.org\/en\/wp-json\/wp\/v2\/posts\/3224\/revisions\/3225"}],"wp:attachment":[{"href":"https:\/\/www.wemos.org\/en\/wp-json\/wp\/v2\/media?parent=3224"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.wemos.org\/en\/wp-json\/wp\/v2\/categories?post=3224"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}